# Boston Scientific Corporation (BSX) — Q1-2021 Earnings Results

**Report date:** 2021-04-28 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 4.32%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | +22.11% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, emphasizing their commitment to growth. They acknowledged market challenges but remain focused on innovation.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing efforts to navigate market challenges.

> The focus remains on innovation and expanding product offerings.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Boston Scientific's strong EPS performance, beating expectations by over 22%, led to a positive stock reaction, with shares rising 4.32%. The absence of revenue figures leaves some uncertainty, but management's focus on innovation suggests a commitment to long-term growth. Investors may view the earnings beat as a sign of resilience in a challenging market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2021_